PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 4beta-hydroxycholesterol. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

8 hits

Bibliografisk träff 2011-07-21

Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.

Goodenough AK, Onorato JM, Ouyang Z, Chang S, Rodrigues AD, Kasichayanula S, Huang SP, Turley W, Burrell R, Bifano M, Jemal M, LaCreta F, Tymiak A, Wang-Iverson D.

Chem Res Toxicol · evaluation study; journal article · DOI 10.1021/tx2001898

Bibliografisk träff 2009-05-20

Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?

Tomalik-Scharte D, Lütjohann D, Doroshyenko O, Frank D, Jetter A, Fuhr U.

Clin Pharmacol Ther · comparative study; journal article · DOI 10.1038/clpt.2009.72

Bibliografisk träff 2008-11-06

4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin.

Diczfalusy U, Kanebratt KP, Bredberg E, Andersson TB, Böttiger Y, Bertilsson L.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1365-2125.2008.03309.x

Bibliografisk träff 2008-03-01

4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.

Diczfalusy U, Miura J, Roh HK, Mirghani RA, Sayi J, Larsson H, Bodin KG, Allqvist A, Jande M, Kim JW, Aklillu E, Gustafsson LL, Bertilsson L.

Pharmacogenet Genomics · research support, non-u.s. gov't; journal article · DOI 10.1097/fpc.0b013e3282f50ee9

Bibliografisk träff 2008-02-12

Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.

Wide K, Larsson H, Bertilsson L, Diczfalusy U.

Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1365-2125.2007.03078.x

Bibliografisk träff 2002-06-20

Metabolism of 4 beta -hydroxycholesterol in humans.

Bodin K, Andersson U, Rystedt E, Ellis E, Norlin M, Pikuleva I, Eggertsen G, Björkhem I, Björkhem I, Diczfalusy U.

J Biol Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.m201712200

Bibliografisk träff 2001-08-20

Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.

Bodin K, Bretillon L, Aden Y, Bertilsson L, Broomé U, Einarsson C, Diczfalusy U.

J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.m105127200

Bibliografisk träff 1995-11-01

Identification and quantitation of cholest-5-ene-3 beta,4 beta-diol in rat liver and human plasma.

Breuer O.

J Lipid Res · research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-2275(20)39708-x